Cargando…
Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research
Merkel cell carcinoma (MCC) is a rare neuroendocrine cutaneous cancer, with incidence of less than 1/100,000, low survival rates and variable response to chemotherapy or immunotherapy. Herein we explore the application of patient tumor organoids (PTOs) in modeling personalized research in this rare...
Autores principales: | Forsythe, Steven D., Erali, Richard A., Laney, Preston, Sivakumar, Hemamylammal, Li, Wencheng, Skardal, Aleksander, Soker, Shay, Votanopoulos, Konstantinos I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380677/ https://www.ncbi.nlm.nih.gov/pubmed/35974123 http://dx.doi.org/10.1038/s41598-022-17921-6 |
Ejemplares similares
-
Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform
por: Forsythe, Steven D., et al.
Publicado: (2023) -
Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput
por: Maloney, Erin, et al.
Publicado: (2020) -
Environmental Toxin Screening Using Human-Derived 3D Bioengineered Liver and Cardiac Organoids
por: Forsythe, Steven D., et al.
Publicado: (2018) -
Optical Tracking and Digital Quantification of Beating Behavior in Bioengineered Human Cardiac Organoids
por: Devarasetty, Mahesh, et al.
Publicado: (2017) -
Exploration of Dynamic Elastic Modulus Changes on Glioblastoma Cell Populations with Aberrant EGFR Expression as a Potential Therapeutic Intervention Using a Tunable Hyaluronic Acid Hydrogel Platform
por: Sivakumar, Hemamylammal, et al.
Publicado: (2017)